| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.3B | $3.4B | $3.1B | $4.3B | $3.9B | $0.7B | $0.5B | $0.6B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B |
| Operating Income | $0.5B | $0.6B | $0.3B | $1.4B | $1.2B | $0.1B | $0.0B | $0.0B |
| Net Income | $0.4B | $0.5B | $0.3B | $1.1B | $0.9B | $0.1B | $0.0B | $0.0B |
| EPS (Basic) | $13.99 | $14.14 | $8.42 | $27.28 | $21.67 | $1.99 | $0.36 | $0.48 |
| EPS (Diluted) | $13.81 | $13.93 | $8.32 | $27.07 | $21.47 | $1.96 | $0.36 | $0.48 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.6B | $4.6B | $4.3B | $4.3B | $3.7B | $2.9B | $2.8B | $2.4B |
| Current Assets | $0.5B | $0.6B | $0.6B | $0.8B | $0.7B | $0.3B | $0.3B | $0.3B |
| Cash & Equivalents | $0.1B | $0.3B | $0.1B | $0.2B | $0.3B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $0.5B | $0.6B | $0.6B | $0.6B | $0.6B | $0.5B | $0.4B | $0.4B |
| Stockholders' Equity | $2.8B | $2.7B | $2.4B | $2.3B | $1.7B | $1.0B | $0.8B | $0.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.8B | $0.5B | $1.3B | $1.0B | $0.4B | $0.2B | $0.3B |
| Investing Cash Flow | $-0.3B | $-0.3B | $-0.3B | $-0.7B | $-0.3B | $-0.2B | $-0.3B | $-0.3B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.4B | $-0.3B | $-0.3B | $-0.6B | $-0.4B | $-0.3B | $0.1B | $-0.0B |